JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

News

Home |
News

All Categories

03 Sep

ImmunoPrecise Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2022

The conference call will be webcast live and will available for replay.
...
READ MORE
04 Aug

ImmunoPrecise Welcomes Vice President of Client Relations and Vice President of Marketing to its Leadership Team, Accelerating Its Growth and Expansion Plans

Dr. Barry Duplantis, Ph.D., promoted to VP of Client Relations and Carla Dahl, appointed to VP of Marketing
...
READ MORE
28 Jul

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2021

Total revenue of $17.9 million, up 27% from $14.1 million in fiscal 2020
...
READ MORE
22 Jul

ImmunoPrecise's PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assays

IPA publishes its scientific paper concerning TATX-03 on bioRxiv
...
READ MORE
15 Jul

ImmunoPrecise to Report Financial Results and Business Highlights for Fiscal Year 2021

IPA to host an earnings conference call via webcast on July 28, 2021, after the close of market
...
READ MORE
22 Jun

Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform

The collaboration provides greater access to solutions that empower scientists to pursue life-changing medicines.
...
READ MORE